# Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease

**Authors:** Masataka Nakamura, Aya Murakami, Dennis W Dickson, Yusuke Yakushiji

PMC · DOI: 10.1093/jnen/nlaf004 · Journal of Neuropathology and Experimental Neurology · 2025-02-05

## TL;DR

The study finds that phosphorylated BRCA1 accumulates in specific types of protein clumps in brain diseases like Lewy body disease, suggesting a role in disease progression.

## Contribution

This study is the first to show that phosphorylated BRCA1 accumulates in brainstem-type and cortical-type Lewy bodies, linking DNA repair dysfunction to LBD pathology.

## Key findings

- Phosphorylated BRCA1 (Ser1423) and BARD1 accumulate in brainstem-type Lewy bodies.
- Only phosphorylated BRCA1 (Ser1423) is found in cortical-type Lewy bodies.
- Cytoplasmic sequestration of phosphorylated BRCA1 may contribute to LBD pathogenesis.

## Abstract

BRCA1 plays important roles in several biological events during the DNA damage response (DDR). We aimed to determine whether cytoplasmic accumulation of BRCA1 or its phosphorylated form, pBRCA1, is specific to cytoplasmic inclusions in tauopathies, or if it also occurs in α-synuclein-positive inclusions in Lewy body disease (LBD). Using brain tissue from pure LBD, LBD with Alzheimer disease (AD) co-pathology (LBD-AD), and control cases, the immunohistochemical distributions of BRCA1, pBRCA1, its binding partner BARD1, and 53BP1 were examined. The results showed that pBRCA1 (Ser1423) and BARD1 accumulated in brainstem-type Lewy bodies (LBs), whereas only pBRCA1 (Ser1423) was present in cortical-type LBs. There was no significant difference in the frequency of pBRCA1 (Ser1423)-positive LBs between the pure LBD and LBD-AD cases. pBRCA1 (Ser1423) was minimally detected in neuronal nuclei in controls and was absent in neuronal nuclei in LBD cases. In control and LBD cases, 53BP1-immunoreactive deposits were present in the neuronal nuclei. Thus, DDR dysfunction due to cytoplasmic sequestration of pBRCA1 (Ser1423) may play a role in LBD pathogenesis. Additionally, the selective accumulation of BARD1 in brainstem-type LBs, but not cortical-type LBs, points to distinct mechanisms in the formation of these inclusion types, offering further insights into LBD pathology.

## Linked entities

- **Genes:** BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672], BARD1 (BRCA1 associated RING domain 1) [NCBI Gene 580], TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158]
- **Diseases:** Lewy body disease (MONDO:0007488), Alzheimer disease (MONDO:0004975)

## Full-text entities

- **Genes:** BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, BARD1 (BRCA1 associated RING domain 1) [NCBI Gene 580], SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}
- **Diseases:** LBD (MESH:D020961), tauopathies (MESH:D024801), AD (MESH:D000544)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11923741/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11923741/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC11923741/full.md

---
Source: https://tomesphere.com/paper/PMC11923741